Pfizer Inc. (NYSE: PFE) and BioNTech SE announced that the U.S. Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) of...
Humanigen, Inc., a clinical-stage biopharmaceutical company focused on preventing and treating an immune hyper-response called ‘cytokine storm’ with its lead drug candidate, lenzilumab, announced...
Onera Health announced Improved Pharma Contributes to Paper Advancing the Study of Sameness of Amorphous Materialsthe introduction of its first Onera Biomedical-Lab-on-Chip™. The biomedical...
Improved Pharma continued collaboration with expert colleagues in the field of amorphous studies has resulted in a new publication. The article can be downloaded...
ABCT, the Accelerator for Biosciences in Connecticut, announced the second cohort of emerging biosciences ventures invited to participate in the annual program. Nine ventures...
